URMC Neurology Research

Neuroimmunology Unit - Rochester MS Center

Scope of Research: Immune Disorders of Nervous System

Focus is cutting-edge clinical research and experimental therapeutics of multiple sclerosis.

Clinical research assessing novel therapies targeted at multiple steps in the pathogenesis of MS lesions
Clinical research evaluating new symptomatic therapies

Clinical research studies of fatigue, cognitive dysfunction, and other aspects of MS

References
Goodman, AD; Rossman, H; Bar-Or, A; Miller, A; Miller, DH; Schmierer, K; Lublin, F; Khan, O; Bormann, NM; Yang, M; Panzara, MA; Sandrock, AW; GLANCE Investigators. "GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study." Neurology 3 (2009): 806-12.

Goodman AD; Brown TR; Drupp LB; Schapiro RT; Schwid SR; Cohen R; Marinucci LN; Blight AR; Fampridine MS-F203 Investigators. "Sustained-release oral fampridine in multiple sclerosis: a randomized double-blind, controlled trial." Lancet. 28 (2009): 697-8.

Goodman AD; Brown TR; Cohen JA; Krupp LB; Schapiro R; Schwid SR; Cohen R; Marinucci LN; Blight AR; . "Dose comparison trial of sustained-release fampridine in multiple sclerosis." Neurology. 2008; 71(15):1134-41. Epub 2008 Jul 30.

Andrew D. Goodman, M.D., Unit Chief
Andrew_Goodman@urmc.rochester.edu
(585) 275-7854